Chantal D.
- Country
- France
- Department
- Oncologie médicale
Research Overview
- Phase III Randomized Controlled Trial of Pembrolizumab with Platinum-Based Chemotherapy Versus Pembrolizumab Monotherapy in First-Line Treatment of NSCLC with PD-L1 ≥50%
- Phase II Study on Durvalumab, Etoposide, and Platinum in First-Line Treatment of Advanced Large-Cell Neuroendocrine Carcinoma of the Lung
- Phase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Non-squamous NSCLC
Data & Insights
Has run more than one trial at 16 of 100 partner sites.
Specializations
Lung Cancer Specialization
This investigator focuses on advanced treatments for non-small cell lung cancer (NSCLC), with particular emphasis on both squamous and non-squamous variants. Their research encompasses therapeutic approaches for patients with PD-L1 expressing tumors.
- Metastatic Squamous NSCLC
- Metastatic Non-squamous NSCLC
- Large-Cell Neuroendocrine Carcinoma
The investigator's work addresses various stages of disease progression, from locally advanced to metastatic conditions.
Immunotherapy Research
A significant focus lies in studying innovative immunotherapy combinations for lung cancer treatment. The investigator explores various therapeutic agents including durvalumab and pembrolizumab in combination with traditional chemotherapy.
- PD-L1 Targeted Therapies
- Combined Immunotherapy Approaches
- First-line Treatment Strategies
Their research evaluates treatment efficacy in specific patient populations with distinct biomarker profiles.
Advanced Treatment Protocols
The investigator specializes in developing treatment protocols for advanced stage lung cancers, particularly focusing on combination therapies. Their work includes evaluation of platinum-based chemotherapy regimens combined with novel agents.
- Combination Therapy Approaches
- Treatment Response Assessment
- Patient-Specific Protocols
Research activities encompass both conventional and innovative therapeutic strategies for optimal patient outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.